- Conditions
- Vaginitis, Vulvar Diseases
- Interventions
- Vaginitis panel
- Diagnostic Test
- Lead sponsor
- University of Virginia
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 91 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2026
- U.S. locations
- 1
- States / cities
- Charlottesville, Virginia
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–24
of 160
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Bacterial Vaginosis
- Interventions
- Metronidazole
- Drug
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 15 Years to 25 Years · Female only
- Enrollment
- 1,370 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2014
- U.S. locations
- 7
- States / cities
- Birmingham, Alabama • San Francisco, California • Baltimore, Maryland + 3 more
- Conditions
- Trichomonas Vaginitis, Bacterial Vaginitis
- Interventions
- Metronidazole 500 mg, Secnidazole 2000 MG
- Drug
- Lead sponsor
- Tulane University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 1,200 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2029
- U.S. locations
- 4
- States / cities
- Birmingham, Alabama • North Miami, Florida • New Orleans, Louisiana
- Conditions
- Papanicolaou Smear
- Interventions
- no-stirrup vaginal examination, Vaginal speculum examination done with stirrups.
- Procedure
- Lead sponsor
- Eisenhower Army Medical Center
- Federal
- Eligibility
- 18 Years and older · Female only
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2010
- U.S. locations
- 1
- States / cities
- Fort Gordon, Georgia
- Conditions
- Vaginitis Gardnerella
- Interventions
- Amoxicillin, Placebo
- Drug · Other
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 18 Years to 45 Years · Female only
- Enrollment
- 97 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2017 – 2019
- U.S. locations
- 2
- States / cities
- Birmingham, Alabama • Winston-Salem, North Carolina
- Conditions
- Vulvovaginal Candidiases, Yeast Infection, Vulvovaginitis, Yeast Infection Vaginal, Candidiasis, Vulvovaginal
- Interventions
- Oral Encochleated Amphotericin B (CAMB)
- Drug
- Lead sponsor
- Matinas BioPharma Nanotechnologies, Inc.
- Industry
- Eligibility
- 18 Years to 65 Years · Female only
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2020
- U.S. locations
- 1
- States / cities
- Detroit, Michigan
- Conditions
- Treponema Pallidum Infection, Chlamydia Trachomatis Infection, Neisseria Gonorrheae Infection, Trichomonas Vaginalis Vaginitis, Sexually Transmitted Infection
- Interventions
- Point-of-care STI tests, Standard of care STI testing
- Diagnostic Test
- Lead sponsor
- Emory University
- Other
- Eligibility
- Female only
- Enrollment
- 756 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2030
- U.S. locations
- 1
- States / cities
- Atlanta, Georgia
- Conditions
- Bacterial Vaginosis
- Interventions
- GDC-229, Metronidazole Vaginal Gel 0.75%, Placebo
- Drug
- Lead sponsor
- Balmoral Medical company
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 871 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2018
- U.S. locations
- 1
- States / cities
- Raleigh, North Carolina
- Conditions
- Vaginal Discharge, Dyspareunia, Female Sexual Dysfunction, Vaginitis, Bacterial Vaginoses
- Interventions
- Tampon-like device for absorption of sexual fluids
- Device
- Lead sponsor
- Atlantic Health System
- Other
- Eligibility
- 25 Years to 50 Years · Female only
- Enrollment
- 30 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021
- U.S. locations
- 1
- States / cities
- Denville, New Jersey
- Conditions
- Sexually Transmitted Infections, HIV Infections
- Interventions
- Not listed
- Lead sponsor
- University of Mississippi Medical Center
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 300 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2012
- U.S. locations
- 1
- States / cities
- Jackson, Mississippi
- Conditions
- Vulvovaginal Candidiasis
- Interventions
- NDV-3A, NDV-3, Placebo
- Biological
- Lead sponsor
- NovaDigm Therapeutics, Inc.
- Industry
- Eligibility
- 18 Years to 50 Years · Female only
- Enrollment
- 188 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2016
- U.S. locations
- 20
- States / cities
- Phoenix, Arizona • Little Rock, Arkansas • San Diego, California + 17 more
- Conditions
- Bacterial Vaginosis
- Interventions
- tinidazole, metronidazole
- Drug
- Lead sponsor
- University of Alabama at Birmingham
- Other
- Eligibility
- 18 Years to 45 Years · Female only
- Enrollment
- 593 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2009
- U.S. locations
- 1
- States / cities
- Birmingham, Alabama
- Conditions
- Bacterial Vaginosis
- Interventions
- Metronidazole, Placebo
- Drug
- Lead sponsor
- Medical University of South Carolina
- Other
- Eligibility
- 18 Years to 45 Years · Female only
- Enrollment
- 59 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2010
- U.S. locations
- 1
- States / cities
- Charleston, South Carolina
- Conditions
- Candida Vulvovaginitis
- Interventions
- Ibrexafungerp, Placebo
- Drug
- Lead sponsor
- Scynexis, Inc.
- Industry
- Eligibility
- 12 Years and older · Female only
- Enrollment
- 455 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2020
- U.S. locations
- 21
- States / cities
- Mesa, Arizona • Lakewood, Colorado • New Haven, Connecticut + 18 more
- Conditions
- Bacterial Vaginosis, Vulvovaginal Candidiasis, Trichomoniasis
- Interventions
- NAAT testing
- Other
- Lead sponsor
- University of Pittsburgh
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 300 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2014 – 2015
- U.S. locations
- 1
- States / cities
- Pittsburgh, Pennsylvania
- Conditions
- Health, Vulvovaginal Candidiasis
- Interventions
- Miconazole nitrate, Magnetic resonance imaging, Moderate levels of exercise
- Drug · Procedure · Behavioral
- Lead sponsor
- University of Pennsylvania
- Other
- Eligibility
- 18 Years to 45 Years · Female only
- Enrollment
- 12 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2004
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
- Conditions
- Atrophic Vaginitis
- Interventions
- IZN-6NVS Cream
- Drug
- Lead sponsor
- Izun Pharma Ltd
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2017
- U.S. locations
- 2
- States / cities
- The Bronx, New York • Seattle, Washington
- Conditions
- Bacterial Vaginosis
- Interventions
- 0.5% SPL7013 Gel, 1.0% SPL7013 Gel, 3.0% SPL7013 Gel, Placebo Gel
- Drug · Other
- Lead sponsor
- Starpharma Pty Ltd
- Industry
- Eligibility
- 18 Years to 45 Years · Female only
- Enrollment
- 132 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2011
- U.S. locations
- 5
- States / cities
- Phoenix, Arizona • Denver, Colorado • Las Vegas, Nevada + 2 more
- Conditions
- Atrophic Vaginitis, Vaginal Atrophy, Genitourinary Syndrome of Menopause, Lichen Sclerosus of Vulva, Lichen Planus of Vulva, Lichen Simplex of Vulva (Disorder)
- Interventions
- 7-0940
- Device
- Lead sponsor
- Stratpharma AG
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 2,000 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2028
- U.S. locations
- 14
- States / cities
- Birmingham, Alabama • Burbank, California • Laguna Hills, California + 11 more
- Conditions
- Bacterial Vaginosis
- Interventions
- Product 55394, Placebo Vehicle (non-treatment)
- Drug
- Lead sponsor
- Medicis Global Service Corporation
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 651 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012
- U.S. locations
- 37
- States / cities
- Birmingham, Alabama • Phoenix, Arizona • La Mesa, California + 34 more
- Conditions
- Menopausal and Perimenopausal Disorder, Unspecified, Atrophic Vaginitis
- Interventions
- Vaginal Lubrication Ring for Vaginal Dryness
- Device
- Lead sponsor
- J3 Bioscience, Inc.
- Industry
- Eligibility
- 35 Years and older · Female only
- Enrollment
- 21 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014
- U.S. locations
- 1
- States / cities
- Salt Lake City, Utah
- Conditions
- Trichomonas Vaginitis
- Interventions
- oral metronidazole, neo penotran forte, neo penotran forte once a day
- Drug
- Lead sponsor
- University of Alabama at Birmingham
- Other
- Eligibility
- 19 Years and older · Female only
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2013
- U.S. locations
- 1
- States / cities
- Birmingham, Alabama
- Conditions
- Bacterial Vaginosis
- Interventions
- Metronidazole
- Drug
- Lead sponsor
- University of Pittsburgh
- Other
- Eligibility
- 18 Years to 26 Years · Female only
- Enrollment
- 12 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2007 – 2010
- U.S. locations
- 2
- States / cities
- Pittsburgh, Pennsylvania
- Conditions
- Atrophic Vaginitis
- Interventions
- Estradiol Vaginal Cream, 0.01%, Estrace® 0.01% cream, Placebo Vaginal Cream
- Drug
- Lead sponsor
- Mylan Pharmaceuticals Inc
- Industry
- Eligibility
- 40 Years to 70 Years · Female only
- Enrollment
- 366 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2014
- U.S. locations
- 21
- States / cities
- Tucson, Arizona • Los Angeles, California • Sacramento, California + 16 more